Australia's CSL reports 2% fall in annual profit
17/08/2026 23:16
Australia's CSL reports 2% fall in annual profit Aug 18 (Reuters) - Australia's CSL CSL.AX on Tuesday posted a 2% fall in annual profit, dragged by declining revenue at its core plasma division.
The company, among the world's top flu vaccine makers, reported underlying net profit after tax attributable of $3.14 billion on a constant currency basis for the year ended June 30, compared with $3.22 billion logged last year.
(Reporting by Sherin Sunny and Nikita Maria Jino in Bengaluru; Editing by Leroy Leo)
((Nikita.Jino@thomsonreuters.com;
Sherin.Sunny@thomsonreuters.com;))